262 related articles for article (PubMed ID: 27657026)
1. Therapeutic Effects of Phytochemicals and Medicinal Herbs on Chemotherapy-Induced Peripheral Neuropathy.
Lee G; Kim SK
Molecules; 2016 Sep; 21(9):. PubMed ID: 27657026
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy-induced peripheral neurotoxicity and complementary and alternative medicines: progress and perspective.
Cheng XL; Liu HQ; Wang Q; Huo JG; Wang XN; Cao P
Front Pharmacol; 2015; 6():234. PubMed ID: 26557088
[TBL] [Abstract][Full Text] [Related]
3. Medicinal plants and their isolated phytochemicals for the management of chemotherapy-induced neuropathy: therapeutic targets and clinical perspective.
Oveissi V; Ram M; Bahramsoltani R; Ebrahimi F; Rahimi R; Naseri R; Belwal T; Devkota HP; Abbasabadi Z; Farzaei MH
Daru; 2019 Jun; 27(1):389-406. PubMed ID: 30852764
[TBL] [Abstract][Full Text] [Related]
4. Herbal medicines and chemotherapy induced peripheral neuropathy (CIPN): A critical literature review.
Schloss J; Colosimo M; Vitetta L
Crit Rev Food Sci Nutr; 2017 Apr; 57(6):1107-1118. PubMed ID: 25849070
[TBL] [Abstract][Full Text] [Related]
5. Analgesic effects of medicinal plants and phytochemicals on chemotherapy-induced neuropathic pain through glial modulation.
Lee JH; Kim N; Park S; Kim SK
Pharmacol Res Perspect; 2021 Dec; 9(6):e00819. PubMed ID: 34676990
[TBL] [Abstract][Full Text] [Related]
6. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).
Schloss JM; Colosimo M; Airey C; Masci P; Linnane AW; Vitetta L
Support Care Cancer; 2017 Jan; 25(1):195-204. PubMed ID: 27612466
[TBL] [Abstract][Full Text] [Related]
7. A review of complementary therapies with medicinal plants for chemotherapy-induced peripheral neuropathy.
Wu BY; Liu CT; Su YL; Chen SY; Chen YH; Tsai MY
Complement Ther Med; 2019 Feb; 42():226-232. PubMed ID: 30670246
[TBL] [Abstract][Full Text] [Related]
8. New Insights into Potential Prevention and Management Options for Chemotherapy-Induced Peripheral Neuropathy.
Schloss J; Colosimo M; Vitetta L
Asia Pac J Oncol Nurs; 2016; 3(1):73-85. PubMed ID: 27981142
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy-induced peripheral neurotoxicity (CIPN): what we need and what we know.
Cavaletti G
J Peripher Nerv Syst; 2014 Jun; 19(2):66-76. PubMed ID: 24976572
[TBL] [Abstract][Full Text] [Related]
10. Goshajinkigan for reducing chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.
Hoshino N; Ganeko R; Hida K; Sakai Y
Int J Clin Oncol; 2018 Jun; 23(3):434-442. PubMed ID: 29270698
[TBL] [Abstract][Full Text] [Related]
11. Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): a systematic review.
Schloss JM; Colosimo M; Airey C; Masci PP; Linnane AW; Vitetta L
Clin Nutr; 2013 Dec; 32(6):888-93. PubMed ID: 23647723
[TBL] [Abstract][Full Text] [Related]
12. Herbal Decoction Divya-Peedantak-Kwath Alleviates Allodynia and Hyperalgesia in Mice Model of Chemotherapy-Induced Peripheral Neuropathy via Modulation in Cytokine Response.
Balkrishna A; Sakat SS; Karumuri S; Singh H; Tomer M; Kumar A; Sharma N; Nain P; Haldar S; Varshney A
Front Pharmacol; 2020; 11():566490. PubMed ID: 33324205
[TBL] [Abstract][Full Text] [Related]
13. Endoplasmic Reticulum Stress in Chemotherapy-Induced Peripheral Neuropathy: Emerging Role of Phytochemicals.
Goel Y; Fouda R; Gupta K
Antioxidants (Basel); 2022 Jan; 11(2):. PubMed ID: 35204148
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy-induced neuropathy in multiple myeloma: influence on quality of life and development of a questionnaire to compose common toxicity criteria grading for use in daily clinical practice.
Beijers AJ; Vreugdenhil G; Oerlemans S; Eurelings M; Minnema MC; Eeltink CM; van de Poll-Franse LV; Mols F
Support Care Cancer; 2016 Jun; 24(6):2411-20. PubMed ID: 26634561
[TBL] [Abstract][Full Text] [Related]
15. Risk-reduction and treatment of chemotherapy-induced peripheral neuropathy.
Bakogeorgos M; Georgoulias V
Expert Rev Anticancer Ther; 2017 Nov; 17(11):1045-1060. PubMed ID: 28868935
[TBL] [Abstract][Full Text] [Related]
16. A prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy-induced peripheral neuropathy.
Stubblefield MD; McNeely ML; Alfano CM; Mayer DK
Cancer; 2012 Apr; 118(8 Suppl):2250-60. PubMed ID: 22488699
[TBL] [Abstract][Full Text] [Related]
17. Considerations for a Reliable In Vitro Model of Chemotherapy-Induced Peripheral Neuropathy.
Eldridge S; Scuteri A; Jones EMC; Cavaletti G; Guo L; Glaze E
Toxics; 2021 Nov; 9(11):. PubMed ID: 34822690
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy-induced peripheral neuropathies: from clinical relevance to preclinical evidence.
Balayssac D; Ferrier J; Descoeur J; Ling B; Pezet D; Eschalier A; Authier N
Expert Opin Drug Saf; 2011 May; 10(3):407-17. PubMed ID: 21210753
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy induced peripheral neuropathic pain.
Park HJ
Korean J Anesthesiol; 2014 Jul; 67(1):4-7. PubMed ID: 25097731
[TBL] [Abstract][Full Text] [Related]
20. PGC1α: an emerging therapeutic target for chemotherapy-induced peripheral neuropathy.
Zhai M; Hu H; Zheng Y; Wu B; Sun W
Ther Adv Neurol Disord; 2023; 16():17562864231163361. PubMed ID: 36993941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
